GlassScriptPhysician profile
Jessica Compton
NPI 1336525914
$498.28
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.35 · 2022: $12.58 · 2023: $109 · 2024: $181 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $107.39 | 2024-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $73.98 | 2023-2024 | Jornay Pm |
| Seqirus USA INC | $51.20 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Biomarin Pharmaceutical INC. | $44.24 | 2024-2025 | Voxzogo 1.2mg |
| Corium, LLC | $39.61 | 2024 | Azstarys |
| Kaleo, INC. | $37.80 | 2021-2022 | |
| Glaxosmithkline, LLC. | $36.66 | 2023-2024 | Bexsero |
| Collegium Pharmaceutical, INC. | $35.77 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $22.57 | 2021 | |
| Sobi, INC | $16.93 | 2023 | |
| Neurelis, INC. | $16.56 | 2021 | |
| Neos Therapeutics, LP | $15.57 | 2023 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.